Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Molecular Mechanisms of Topical Anti-Inflammatory Effects of Lipoxin A4 in Endotoxin-Induced Uveitis

Rodrigo Medeiros, Gustavo Büchele Rodrigues, Cláudia Pinto Figueiredo, Eduardo Büchele Rodrigues, Astor Grumman Jr., Octavio Menezes-de-Lima Jr., Giselle Fazzioni Passos and João Batista Calixto
Molecular Pharmacology July 2008, 74 (1) 154-161; DOI: https://doi.org/10.1124/mol.108.046870
Rodrigo Medeiros
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gustavo Büchele Rodrigues
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cláudia Pinto Figueiredo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo Büchele Rodrigues
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Astor Grumman Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Octavio Menezes-de-Lima Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giselle Fazzioni Passos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
João Batista Calixto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Lipoxin A4 (LXA4) is a lipid mediator that plays an important role in inflammation resolution. We assessed the anti-inflammatory effect of LXA4 on endotoxin-induced uveitis (EIU) in rats. The inflammatory cell number and levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), prostaglandin E2 (PGE2), and protein, as well as expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF), in the anterior chamber of the eye were determined 24 h after lipopolysaccharide (LPS; 200 μg/paw) intradermal injection. The immunohistochemical reactivities of nuclear factor-κB (NF-κB) and c-Jun were also examined. Topical LXA4 (1-10 ng/eye) pretreatment decreased the number of inflammatory cells and the protein leakage into the aqueous humor (AqH). In addition, topical LXA4 (10 ng/eye) inhibited the LPS-induced production of IL-1β, TNF-α, and PGE2, and expression of COX-2 and VEGF. A decreased activation of NF-κB and c-Jun was also found in LXA4-treated eyes. It is very interesting that an anti-inflammatory effect was achieved even when LXA4 (10 ng/eye) was applied topically after LPS challenge, as indicated by the reduction in the cellular and protein extravasations into the AqH. Moreover, topical treatment of corticosteroid prednisolone (200 μg/eye) beginning before or after LPS injection reduced all of the molecular and biochemical alterations promoted on EIU rats in an efficacy similar to that of LXA4. Together, the present results provide clear evidence that pharmacological activation of LXA4 signaling pathway potently reduces the EIU in rats. Therefore, LXA4 stable analogs could represent promising agents for the management of ocular inflammatory diseases.

Footnotes

  • This work was supported by grants from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, and the Programa de Apoio aos Núcleos de Excelência, all from Brazil. G.B.R. is an undergraduate medical student receiving a grant from CNPq. G.F.P. is a Ph.D. student in pharmacology receiving grants from CNPq. R.M. and O.M.L.J. are supported by a postdoctoral fellowship granted by CNPq.

  • R.M. and G.B.R. contributed equally to this work.

  • ABBREVIATIONS: LXA4, lipoxin A4; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; PGE2, prostaglandin E2; COX, cyclooxygenase; VEGF, vascular endothelial growth factor; LPS, lipopolysaccharide; NF-κB, nuclear factor-κB; AqH, aqueous humor; EIU, endotoxin induced uveitis; i.pl., intraplantar; PBS, phosphate-buffered saline; ICB, iris ciliary body; AP-1, activator protein-1.

  • ↵ Embedded Image The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.

    • Received March 3, 2008.
    • Accepted April 14, 2008.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 74 (1)
Molecular Pharmacology
Vol. 74, Issue 1
1 Jul 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Mechanisms of Topical Anti-Inflammatory Effects of Lipoxin A4 in Endotoxin-Induced Uveitis
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Molecular Mechanisms of Topical Anti-Inflammatory Effects of Lipoxin A4 in Endotoxin-Induced Uveitis

Rodrigo Medeiros, Gustavo Büchele Rodrigues, Cláudia Pinto Figueiredo, Eduardo Büchele Rodrigues, Astor Grumman, Octavio Menezes-de-Lima, Giselle Fazzioni Passos and João Batista Calixto
Molecular Pharmacology July 1, 2008, 74 (1) 154-161; DOI: https://doi.org/10.1124/mol.108.046870

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Molecular Mechanisms of Topical Anti-Inflammatory Effects of Lipoxin A4 in Endotoxin-Induced Uveitis

Rodrigo Medeiros, Gustavo Büchele Rodrigues, Cláudia Pinto Figueiredo, Eduardo Büchele Rodrigues, Astor Grumman, Octavio Menezes-de-Lima, Giselle Fazzioni Passos and João Batista Calixto
Molecular Pharmacology July 1, 2008, 74 (1) 154-161; DOI: https://doi.org/10.1124/mol.108.046870
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics